Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 2
1964 2
1965 1
1967 1
1968 1
1970 2
1971 3
1972 2
1973 1
1977 1
1978 2
1979 1
1980 1
1981 1
1982 5
1983 5
1984 3
1985 2
1987 3
1988 5
1989 5
1990 6
1991 7
1992 8
1993 9
1994 7
1995 11
1996 10
1997 14
1998 12
1999 14
2000 6
2001 6
2002 13
2003 17
2004 6
2005 21
2006 11
2007 17
2008 13
2009 17
2010 21
2011 32
2012 35
2013 30
2014 37
2015 37
2016 22
2017 24
2018 21
2019 24
2020 24
2021 13
2022 9
2023 10
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

527 results

Results by year

Filters applied: . Clear all
Page 1
First-Line Venetoclax Combinations in Chronic Lymphocytic Leukemia.
Eichhorst B, Niemann CU, Kater AP, Fürstenau M, von Tresckow J, Zhang C, Robrecht S, Gregor M, Juliusson G, Thornton P, Staber PB, Tadmor T, Lindström V, da Cunha-Bang C, Schneider C, Poulsen CB, Illmer T, Schöttker B, Nösslinger T, Janssens A, Christiansen I, Baumann M, Frederiksen H, van der Klift M, Jäger U, Leys MBL, Hoogendoorn M, Lotfi K, Hebart H, Gaska T, Koene H, Enggaard L, Goede J, Regelink JC, Widmer A, Simon F, De Silva N, Fink AM, Bahlo J, Fischer K, Wendtner CM, Kreuzer KA, Ritgen M, Brüggemann M, Tausch E, Levin MD, van Oers M, Geisler C, Stilgenbauer S, Hallek M; GCLLSG, the HOVON and Nordic CLL Study Groups, the SAKK, the Israeli CLL Association, and Cancer Trials Ireland. Eichhorst B, et al. N Engl J Med. 2023 May 11;388(19):1739-1754. doi: 10.1056/NEJMoa2213093. N Engl J Med. 2023. PMID: 37163621 Clinical Trial.
Fedratinib in patients with myelofibrosis previously treated with ruxolitinib: An updated analysis of the JAKARTA2 study using stringent criteria for ruxolitinib failure.
Harrison CN, Schaap N, Vannucchi AM, Kiladjian JJ, Jourdan E, Silver RT, Schouten HC, Passamonti F, Zweegman S, Talpaz M, Verstovsek S, Rose S, Shen J, Berry T, Brownstein C, Mesa RA. Harrison CN, et al. Among authors: schouten hc. Am J Hematol. 2020 Jun;95(6):594-603. doi: 10.1002/ajh.25777. Epub 2020 Apr 17. Am J Hematol. 2020. PMID: 32129512 Free PMC article. Clinical Trial.
Janus kinase-2 inhibitor fedratinib in patients with myelofibrosis previously treated with ruxolitinib (JAKARTA-2): a single-arm, open-label, non-randomised, phase 2, multicentre study.
Harrison CN, Schaap N, Vannucchi AM, Kiladjian JJ, Tiu RV, Zachee P, Jourdan E, Winton E, Silver RT, Schouten HC, Passamonti F, Zweegman S, Talpaz M, Lager J, Shun Z, Mesa RA. Harrison CN, et al. Among authors: schouten hc. Lancet Haematol. 2017 Jul;4(7):e317-e324. doi: 10.1016/S2352-3026(17)30088-1. Epub 2017 Jun 8. Lancet Haematol. 2017. PMID: 28602585 Free PMC article. Clinical Trial.
Myeloproliferative neoplasm (MPN) symptom assessment form total symptom score: prospective international assessment of an abbreviated symptom burden scoring system among patients with MPNs.
Emanuel RM, Dueck AC, Geyer HL, Kiladjian JJ, Slot S, Zweegman S, te Boekhorst PA, Commandeur S, Schouten HC, Sackmann F, Kerguelen Fuentes A, Hernández-Maraver D, Pahl HL, Griesshammer M, Stegelmann F, Doehner K, Lehmann T, Bonatz K, Reiter A, Boyer F, Etienne G, Ianotto JC, Ranta D, Roy L, Cahn JY, Harrison CN, Radia D, Muxi P, Maldonado N, Besses C, Cervantes F, Johansson PL, Barbui T, Barosi G, Vannucchi AM, Passamonti F, Andreasson B, Ferrari ML, Rambaldi A, Samuelsson J, Birgegard G, Tefferi A, Mesa RA. Emanuel RM, et al. Among authors: schouten hc. J Clin Oncol. 2012 Nov 20;30(33):4098-103. doi: 10.1200/JCO.2012.42.3863. Epub 2012 Oct 15. J Clin Oncol. 2012. PMID: 23071245 Free PMC article.
Neutropenia management.
Schouten HC. Schouten HC. Ann Oncol. 2006 Sep;17 Suppl 10:x85-9. doi: 10.1093/annonc/mdl243. Ann Oncol. 2006. PMID: 17018758 Free article. Review. No abstract available.
[Perioral treatment options in cosmetic facial surgery].
Bierenbroodspot F, Schouten HJ, Schepers RH, Jansma J. Bierenbroodspot F, et al. Among authors: schouten hj. Ned Tijdschr Tandheelkd. 2017 Jun;124(6):325-332. doi: 10.5177/ntvt.2017.06.16234. Ned Tijdschr Tandheelkd. 2017. PMID: 28643824 Review. Dutch.
General principles of treatment.
Schouten HC. Schouten HC. Ann Oncol. 2007 Jan;18 Suppl 1:i29-i32. doi: 10.1093/annonc/mdl447. Ann Oncol. 2007. PMID: 17311818 Free article. Review. No abstract available.
Response evaluation and long-term follow-up.
Schouten HC. Schouten HC. Ann Oncol. 2007 Jan;18 Suppl 1:i33-i36. doi: 10.1093/annonc/mdl448. Ann Oncol. 2007. PMID: 17311820 Free article. Review. No abstract available.
527 results